Palladacarboxamide Capping Reagents for Carbon Isotope Labeling and Pharmaceutical Diversification
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.1188892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Daniel V Hoffmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Nanoscience Center (iNANO), Department of Chemistry, Aarhus University, Gustav Wieds Vej 14, Aarhus C, Denmark. Hauptthemen laut MEDLINE: Palladium, Amides, Organometallic Compounds. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie, Novo Nordisk Fonden.
Abstract (Originalsprache)
Radiolabeling of bioactive molecules is essential for elucidating their pharmacokinetic and pharmacodynamic properties. Aryl carboxamides represent common constituents in a wide number of pharmaceuticals. Herein, we present a direct approach for the 14 C‐labeling of this functional group facilitated by organometallic carboxamide capping reagents, based on palladium. Near stoichiometric amounts of 14 CO are readily generated from a 14 CO surrogate and exploited to assemble a range of palladium oxidative addition complexes. When subjected to Suzuki cross‐coupling conditions with boronic acids or esters, structurally diverse high‐value aryl carboxamides can be accessed directly. The protocol's robustness is demonstrated by late‐stage modification of amine‐displaying small drug molecules with 14 C‐incorporation. Since the organometallic carboxamide complexes are air stable, this protocol provides a simple and direct means for carbon isotope labeling, which can easily be adapted to drug development programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Nanoscience Center (iNANO), Department of Chemistry, Aarhus University, Gustav Wieds Vej 14, Aarhus C, Denmark.
- Early Chemical Development, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal, Sweden.
- Early Chemical Development, Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, Massachusetts, USA.
ORCID-Profile: Charles S Elmore, Troels Skrydstrup
Förderung
- Novo Nordisk Foundation
- European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie
- Novo Nordisk Fonden
Zitieren
APA
Hoffmann, D. V., Schick, A., Kjær, L., Enemærke, V. J., Kaussler, C., Torp, J., Martínez-Pardo, P., Elmore, C. S., & Skrydstrup, T. (2026). Palladacarboxamide Capping Reagents for Carbon Isotope Labeling and Pharmaceutical Diversification. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.1188892
Vancouver
Hoffmann DV, Schick A, Kjær L, Enemærke VJ, Kaussler C, Torp J, et al. Palladacarboxamide Capping Reagents for Carbon Isotope Labeling and Pharmaceutical Diversification. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.1188892
BibTeX
@article{Hoffmann2026,
author = {Hoffmann, Daniel V and Schick, Anika and Kjær, Lasse and Enemærke, Vitus J and Kaussler, Clemens and Torp, Jens and Martínez-Pardo, Pablo and Elmore, Charles S and Skrydstrup, Troels},
title = {Palladacarboxamide Capping Reagents for Carbon Isotope Labeling and Pharmaceutical Diversification},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.1188892}
}
EUVIMED